Management of Patients With Chronic Coronary Disease

This JAMA Clinical Guidelines Synopsis summarizes the 2023 American Heart Association (AHA)/American College of Cardiology (ACC) guideline on management of patients with chronic coronary disease.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JAMA : the journal of the American Medical Association 2024-08, Vol.332 (7), p.585-586
Hauptverfasser:	German, Charles A, Davis, Andrew M, Polonsky, Tamar S
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic beta-Antagonists - standards Adrenergic beta-Antagonists - therapeutic use Chronic Disease Coronary Disease - diagnosis Coronary Disease - prevention & control Coronary Disease - therapy Diet, Healthy - standards Drug Therapy, Combination - methods Drug Therapy, Combination - standards Endovascular Procedures - standards Exercise - standards Heart diseases Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - standards Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Sodium-Glucose Transporter 2 Inhibitors - standards Sodium-Glucose Transporter 2 Inhibitors - therapeutic use Stroke Volume
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This JAMA Clinical Guidelines Synopsis summarizes the 2023 American Heart Association (AHA)/American College of Cardiology (ACC) guideline on management of patients with chronic coronary disease.
ISSN:	0098-7484 1538-3598 1538-3598
DOI:	10.1001/jama.2024.9813